Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +)

Status Completed

Clinical Trial Summary

Evodial +hemodialyzer consists of an evolution of the existing CE marked Evodial device, with respect to the hemodialyzer membrane removal characteristics. Different membrane prototypes configurations are proposed (3 versions in total), with the objective to modulate the hemodialyzer removal capacities (convective and adsorptive capacities).

Materials(including heparin grafted specifications) as well as the sterilization process are identical to the Evodial hemodialyzer. Based on available preclinical data , a clinical study is requested to document in vivo the different prototypes removal capacities with respect to middle Molecular Weight (MW) reference toxins such as b2 Microglobulin and collect data with regards to protein loss.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01783626
Study type	Interventional
Source	Baxter Healthcare Corporation
Contact
Status	Completed
Phase	N/A
Start date	October 2012
Completion date	March 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05908084` - To Compare the Efficacy and Safety of the HAV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis	Phase 3
Active, not recruiting	`NCT05309109` - Effect of Medium Cut-Off Hemodialysis on Protein Energy Wasting: The EMCOPEW Study	N/A
Not yet recruiting	`NCT04086212` - Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine	Phase 2
Active, not recruiting	`NCT01693263` - Outcome of BCF Access in Hemodialysis Patients
Completed	`NCT01219959` - Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients	Phase 3
Completed	`NCT02278341` - Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis	Phase 3
Completed	`NCT02593149` - Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap	N/A
Withdrawn	`NCT02274896` - Bayston Multicenter Antimicrobial PD Catheter Safety Study	N/A
Completed	`NCT04912050` - EXtension of Tablo TrEatmeNt Duration Registry
Recruiting	`NCT02745340` - Substitution of Acetate by Citrate in the Bicarbonate Based Hemodialysis	N/A
Completed	`NCT02733328` - Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study
Completed	`NCT04292184` - Evaluation of Thiosulfate in End Stage Renal Disease and Kidney Transplantation	Phase 1
Completed	`NCT02795286` - Automated Setting of Individualized Sodium Technology	N/A
Active, not recruiting	`NCT02808208` - Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure	Phase 1/Phase 2
Completed	`NCT00559767` - Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium	N/A
Completed	`NCT02433210` - A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients	N/A
Completed	`NCT01594424` - A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation	Phase 1/Phase 2
Completed	`NCT05610683` - Comparison of the Removal of Uremic Toxins With Medium Cut-off and Super High-flux Vitamin E-coated Dialyzers	N/A
Completed	`NCT03249532` - Effect of Dialysis Techniques on Blood Pressure and Cardiac Function During Dialysis	N/A
Completed	`NCT02467530` - Food Preparation Effects on Gut Bacteria in Patients on Peritoneal Dialysis	N/A